Esperoct

Indicated For

hemophilia A

About This Medication

# Novo Nordisk Patient Assistance Program (PAP) Patient Guide: How to Get Esperoct at Low or No Cost Esperoct (turoctocog alfa pegol) is a prescription medicine used to treat and prevent bleeding episodes in adults and children with **hemophilia A**, a genetic bleeding disorder where blood does not clot properly.[2] The **Novo Nordisk Patient Assistance Program (PAP)** offers Esperoct **free of charge** to eligible patients who cannot afford their medication, with no registration fees or monthly costs.[1][5] ## About Esperoct and Hemophilia A Esperoct is an **extended half-life factor VIII therapy** designed for **routine prophylaxis** (regular treatment to prevent bleeds), **on-demand treatment** of bleeding episodes, and **perioperative management** (control of bleeding during surgery).[2] Unlike short-acting factor treatments, Esperoct's pegylation technology allows for fewer infusions per week, potentially improving quality of life for people with hemophilia A.[2] It is **not indicated** for von Willebrand disease.[2] Hemophilia A affects about 1 in 5,000 male births and requires lifelong treatment to replace missing clotting factor VIII. Without proper management, spontaneous or injury-related bleeds can damage joints, muscles, and organs. Esperoct helps reduce bleeding frequency when used prophylactically.[2] ## Who Qualifies for the Program? The Novo Nordisk PAP is for **uninsured or underinsured U.S. patients** facing financial hardship. Key eligibility criteria include:[5] - **U.S. citizen or legal resident**. - **No prescription coverage** (e.g., no HMO, PPO, or other insurance that covers the medication).[5] - Prescribed a Novo Nordisk hemophilia factor product like Esperoct for an indicated condition.[5] - **Household income at or below 400% of the Federal Poverty Level (FPL)**.[5] - Not enrolled in government programs like Medicaid (unless denied) or Medicare LIS (Low-Income Subsidy).[3][5] **Medicare Part D patients** no longer need to meet a $1,000 out-of-pocket spend threshold.[1] Patients eligible for Medicaid or Medicare LIS **must submit a denial letter**.[3] **Important 2026 Update**: Some Novo Nordisk medicines are no longer covered by PAP. Confirm Esperoct eligibility by calling 1-844-668-6732 or checking the program list.[1] ## Income Eligibility Breakdown Eligibility is based on **total household income** compared to **400% FPL**. Use the table below for 2026 guidelines (FPL adjusts annually; verify current levels via HHS.gov or program contact). These are approximate U.S. guidelines for the 48 contiguous states + DC.[5] | Household Size | Annual Income Limit (400% FPL) | |----------------|-------------------------------| | 1 (Individual) | $60,320 | | 2 (Couple) | $81,760 | | 3 | $103,200 | | 4 | $124,640 | *Add ~$21,440 per additional person. Alaska/Hawaii have higher limits. Income includes wages, Social Security, etc. Provide proof like tax returns or pay stubs.*[5] ## Insurance Requirements Patients **must not have prescription coverage** through private insurance (HMO/PPO), employer plans, or government programs that cover Esperoct.[5] If insured, explore **co-pay assistance** or **coverage gap programs** via NovoCare at 1-844-668-6732 first.[2] Medicare patients qualify without prior spend-down, but LIS-eligible must apply for denial.[1][3] **Do not bill insurance** for free PAP product.[5] ## Step-by-Step Application Process 1. **Get Prescribed**: Ask your doctor to prescribe Esperoct and complete **Part 1** of the PAP application (prescriber signature and date required).[5][8] 2. **Download Form**: Get the **Novo Nordisk Hemophilia PAP Application** (Spanish available).[5] Or call **1-844-668-6732** for help.[2] 3. **Complete Patient Section**: Fill **Part 3** (patient certification and signature). Opt for phone/text alerts if desired.[1][8] 4. **Gather Documents**: See required list below. Attach all.[5][8] 5. **Submit**: Mail or fax to address on form. Doctor may eRx to Neovance Specialty Pharmacy (NPI 1780811125).[3] 6. **Wait for Approval**: Processed in **2 business days** if complete; delays for missing info.[1] Get letter, SMS, or automated call.[1][8] **Required Documents** (not exhaustive; confirm with program):[5][8] - Proof of income (tax return, W-2, pay stubs, SSA award letter). - Proof of residency (ID, utility bill). - Insurance denial letter (if applicable). - Prescriber details and prescription. ## Timeline and Delivery - **Processing**: 2 business days (complete apps only).[1][8] - **Notification**: Mail letter + optional phone/text.[1] - **Delivery**: Call from **Neovance Specialty Pharmacy at 1-800-488-5908** to schedule **home shipment within 5 business days**.[1][3] Or to doctor's office/HCP (up to 10-14 business days).[8] - **Refills**: Annual re-enrollment; phone/text for coordination.[3] Shipped free to your home or chosen address. Product availability may change.[1] ## Alternatives if Denied or Ineligible - **Interim Product Program**: Bridge during coverage gaps; call 1-844-668-6732.[2] - **Free Trial Prescription**: Try Esperoct; contact NovoCare.[2][6] - **QuickCheck Benefits Verification**: Find coverage options.[2] - **Co-Pay Savings**: If insured, via NovoCare.[2] - **Other PAPs**: Search RxAssist.org or NeedyMeds.org. - **State Programs**: Check for hemophilia assistance. - **Biosimilars**: None listed currently.[ ] **Reapply** if circumstances change (e.g., job loss).[8] ## Disclaimer This guide is for informational purposes based on publicly available data as of 2026. **Novo Nordisk reserves the right to modify or cancel the PAP without notice**.[1] Eligibility, product availability, and guidelines can change. **Always contact NovoCare at 1-844-668-6732** or visit NovoCare.com for latest details. Not legal/medical advice—consult your doctor. Do not resell or bill for free product.[5] Word count: 1028.

Program information last verified: March 30, 2026